1. Home
  2. Pharma & Healthcare
  3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Status and Forecast 2021-2027

Global Hereditary Transthyretin Amyloidosis (HATTR) Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 117 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Hereditary Transthyretin Amyloidosis (HATTR) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Hereditary Transthyretin Amyloidosis (HATTR) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Hereditary Transthyretin Amyloidosis (HATTR) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Hereditary Transthyretin Amyloidosis (HATTR) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Hereditary Transthyretin Amyloidosis (HATTR) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Hereditary Transthyretin Amyloidosis (HATTR) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Oral
Subcutaneous Injection
Others

Segmented by Application
Hospital
Clinic
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Prothena
Pfizer
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics Inc
Alnylam Pharmaceuticals
Akcea Therapeutics


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Status and Forecast (2016-2027)
1.3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Hereditary Transthyretin Amyloidosis (HATTR) Supply by Company
2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value by Company
2.2 Hereditary Transthyretin Amyloidosis (HATTR) Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Hereditary Transthyretin Amyloidosis (HATTR) Market Status by Type
3.1 Hereditary Transthyretin Amyloidosis (HATTR) Type Introduction
3.1.1 Oral
3.1.2 Subcutaneous Injection
3.1.3 Others
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Hereditary Transthyretin Amyloidosis (HATTR) Market Status by Application
4.1 Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Status by Region
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market by Region
5.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Status
5.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Status
5.4 Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Status
5.5 Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Market Status
5.6 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Status
6 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Status
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Status
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Status
8.1 Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Market Status
9.1 Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Status
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Type and by Application
12.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Forecast (2022-2027)
12.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Type
12.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecast by Application
13 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Region/Country
13.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Prothena
14.1.1 Company Information
14.1.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.1.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Pfizer
14.2.1 Company Information
14.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.2.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Lonis Pharmaceuticals
14.3.1 Company Information
14.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.3.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Eidos Therapeutics
14.4.1 Company Information
14.4.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.4.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Corino Therapeutics Inc
14.5.1 Company Information
14.5.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.5.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Alnylam Pharmaceuticals
14.6.1 Company Information
14.6.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.6.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Akcea Therapeutics
14.7.1 Company Information
14.7.2 Hereditary Transthyretin Amyloidosis (HATTR) Product Introduction
14.7.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
...
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Company (2019-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Hereditary Transthyretin Amyloidosis (HATTR) Sales Area
Table Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sals Value Market Share by Type (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Type (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Type (2016-2021)
Table Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Type (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Application (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Application (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Application (2016-2021)
Table Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value Market Share by Application (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Region (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Region (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Country (2016-2021)
Table North America Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Country (2016-2021)
Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country (2016-2021)
Table Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share by Country (2016-2021)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value (Million USD) Forecast by Type (2022-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share Forecast by Type (2022-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value (Million USD) Forecast by Application (2022-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share Forecast by Application (2022-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value (Million USD) Forecast by Region (2022-2027)
Table Global Hereditary Transthyretin Amyloidosis (HATTR) Value Market Share Forecast by Region (2022-2027)
Table Prothena Company Information
Table Prothena Product Introduction
Table Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Pfizer Company Information
Table Pfizer Product Introduction
Table Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Lonis Pharmaceuticals Company Information
Table Lonis Pharmaceuticals Product Introduction
Table Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Eidos Therapeutics Company Information
Table Eidos Therapeutics Product Introduction
Table Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Corino Therapeutics Inc Company Information
Table Corino Therapeutics Inc Product Introduction
Table Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Alnylam Pharmaceuticals Company Information
Table Alnylam Pharmaceuticals Product Introduction
Table Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)
Table Akcea Therapeutics Company Information
Table Akcea Therapeutics Product Introduction
Table Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets